Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2018
Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer
R D Nipp, A El-Jawahri, M Ruddy, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 4, 2014
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression
D Li, S Pant, D P Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2009
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
P C Enzinger, D P Ryan, J W Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study
R Garcia-Carbonero, J G Supko, R G Maki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer
L S Blaszkowsky, D P Ryan, J Szymonifka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 11, 2011
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma
J A Chan, L S Blaszkowsky, P C Enzinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle
A L Hamilton, J P Eder, A C Pavlick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy
R Garcia-Carbonero, J G Supko, J Manola, et al.
British Journal of Cancer
|
June 25, 2014
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
A F Hezel, M S Noel, J N Allen, et al.
Molecular Psychiatry
|
April 5, 2017
A paternal methyl donor-rich diet altered cognitive and neural functions in offspring mice
D P Ryan, K S Henzel, B L Pearson, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2018
Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer
R D Nipp, A El-Jawahri, M Ruddy, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 4, 2014
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression
D Li, S Pant, D P Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2009
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
P C Enzinger, D P Ryan, J W Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study
R Garcia-Carbonero, J G Supko, R G Maki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer
L S Blaszkowsky, D P Ryan, J Szymonifka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 11, 2011
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma
J A Chan, L S Blaszkowsky, P C Enzinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle
A L Hamilton, J P Eder, A C Pavlick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy
R Garcia-Carbonero, J G Supko, J Manola, et al.
British Journal of Cancer
|
June 25, 2014
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
A F Hezel, M S Noel, J N Allen, et al.
Molecular Psychiatry
|
April 5, 2017
A paternal methyl donor-rich diet altered cognitive and neural functions in offspring mice
D P Ryan, K S Henzel, B L Pearson, et al.
Page
of 10